From the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38105,; Interdisciplinary Program, College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163.
Pacific Northwest Research Institute, Seattle, Washington 98122.
J Biol Chem. 2011 Mar 11;286(10):8481-8492. doi: 10.1074/jbc.M110.174516. Epub 2011 Jan 3.
The ATP-binding cassette (ABC) transporter ABCB6 is a mitochondrial porphyrin transporter that activates porphyrin biosynthesis. ABCB6 lacks a canonical mitochondrial targeting sequence but reportedly traffics to other cellular compartments such as the plasma membrane. How ABCB6 reaches these destinations is unknown. In this study, we show that endogenous ABCB6 is glycosylated in multiple cell types, indicating trafficking through the endoplasmic reticulum (ER), and has only one atypical site for glycosylation (NXC) in its amino terminus. ABCB6 remained glycosylated when the highly conserved cysteine (Cys-8) was substituted with serine to make a consensus site, NXS. However, this substitution blocked ER exit and produced ABCB6 degradation, which was mostly reversed by the proteasomal inhibitor MG132. The amino terminus of ABCB6 has an additional highly conserved ER luminal cysteine (Cys-26). When Cys-26 was mutated alone or in combination with Cys-8, it also resulted in instability and ER retention. Further analysis revealed that these two cysteines form a disulfide bond. We discovered that other ABC transporters with an amino terminus in the ER had similarly configured conserved cysteines. This analysis led to the discovery of a disease-causing mutation in the sulfonylurea receptor 1 (SUR1)/ABCC8 from a patient with hyperinsulinemic hypoglycemia. The mutant allele only contains a mutation in a conserved amino-terminal cysteine, producing SUR1 that fails to reach the cell surface. These results suggest that for ABC transporters the propensity to form a disulfide bond in the ER defines a unique checkpoint that determines whether a protein is ER-retained.
三磷酸腺苷结合盒(ABC)转运蛋白 ABCB6 是一种线粒体卟啉转运蛋白,可激活卟啉生物合成。ABCB6 缺乏典型的线粒体靶向序列,但据报道可转运到其他细胞区室,如质膜。ABCB6 如何到达这些目的地尚不清楚。在这项研究中,我们表明内源性 ABCB6 在多种细胞类型中发生糖基化,表明其通过内质网(ER)运输,并且其氨基末端只有一个非典型的糖基化位点(NXC)。当高度保守的半胱氨酸(Cys-8)被替换为丝氨酸以形成共识位点 NXS 时,ABCB6 仍保持糖基化。然而,这种取代阻止了 ER 出口并产生了 ABCB6 降解,而蛋白酶体抑制剂 MG132 则大部分逆转了这种降解。ABCB6 的氨基末端还有一个额外的高度保守的 ER 腔半胱氨酸(Cys-26)。当 Cys-26 单独或与 Cys-8 一起突变时,也会导致不稳定和 ER 滞留。进一步的分析表明,这两个半胱氨酸形成二硫键。我们发现 ER 中的氨基末端具有类似配置的保守半胱氨酸的其他 ABC 转运蛋白。这种分析导致在患有高胰岛素血症性低血糖的患者中发现了磺酰脲受体 1(SUR1)/ABCC8 的致病突变。突变等位基因仅包含一个保守氨基末端半胱氨酸的突变,产生无法到达细胞表面的 SUR1。这些结果表明,对于 ABC 转运蛋白,在 ER 中形成二硫键的倾向定义了一个独特的检查点,该检查点决定了蛋白质是否在 ER 中保留。